Dupixent 300 MG/2 ML syringe 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26FNS6C
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $63,443
Award facts
- Contract value 100% obligated
- $63,442.75 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $63,442.75 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 ml syringes, with a completion date of February 2, 2026. This non-set-aside contract was competitively awarded on January 30, 2026, with fulfillment to occur at the contractor's facility in Conshohocken, Pennsylvania. Dupixent (dupilumab) is a biologic medication commonly used to treat moderate-to-severe atopic dermatitis, eosinophilic esophagitis, and asthma conditions, making this delivery order part of the Defense Health Agency's pharmaceutical supply chain supporting military treatment facilities and veteran healthcare programs.
This delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s broader Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999 million through December 31, 2031. This comprehensive IDC enables Cencora to supply an extensive range of pharmaceutical products, medical supplies, brand-name and generic medications, vaccines, and specialty healthcare commodities globally to support military healthcare operations. AmerisourceBergen, as a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has demonstrated consistent capability in fulfilling federal medical procurement requirements through open competition across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DR26FNS6C?
SPE2DR26FNS6C was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 30, 2026.
How much is contract SPE2DR26FNS6C worth?
The government has obligated $63,443 on SPE2DR26FNS6C.
Is contract SPE2DR26FNS6C an order under another contract?
Yes. SPE2DR26FNS6C is a delivery order under SPE2DR25D1021, an indefinite delivery contract.
Was contract SPE2DR26FNS6C competed?
The extent of competition for SPE2DR26FNS6C was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award